Polar Capital Holdings’s BioNTech BNTX Stock Holding History

Polar Capital Holdings’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-225,000	Closed	-$24.6M	–	358
2021 Q1	$24.6M	Buy	+225,000	New	+$23.9M	0.15%	138

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Polar Capital Holdings's BNTX Position: Q2 2021 in Review

Polar Capital Holdings sold out of BioNTech (BNTX) in Q2 2021, closing a stake of 225,000 shares — an estimated $24.6M sold.

Polar Capital Holdings first reported a position in BNTX in Q1 2021 and held it in 1 quarter. The position peaked at $24.6M in Q1 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2021.

Polar Capital Holdings reported no remaining BioNTech position as of Q2 2021 after selling out during the quarter.
Polar Capital Holdings sold 225,000 BioNTech shares in Q2 2021, an estimated $24.6M.
Polar Capital Holdings first reported a position in BioNTech in Q1 2021 and held it in 1 quarter.
Polar Capital Holdings's BioNTech position peaked at $24.6M in Q1 2021.
283 funds tracked by Wall St. Rank held BioNTech as of Q2 2021.

Based on Polar Capital Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.